Verve Therapeutics
VERV
VERV was delisted on the 24th of July, 2025.
1 hedge funds and large institutions have $344K invested in Verve Therapeutics in 2025 Q4 according to their latest regulatory filings, with funds opening new positions, 0 increasing their positions, 0 reducing their positions, and 5 closing their positions.
0.26% less ownership
Funds ownership: 0.26% → 0% (-0.26%)
72% less capital invested
Capital invested by funds: $1.24M → $344K (-$899K)
83% less funds holding
Funds holding: 6 → 1 (-5)
100% less first-time investments, than exits
New positions opened: 0 | Existing positions closed: 5
Top Buyers
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
GCM
Greenland Capital Management
New York
|
-$556K |
| 2 |
BIG
Brooklyn Investment Group
Brooklyn,
New York
|
-$197K |
| 3 |
IA
IFP Advisors
Tampa,
Florida
|
-$112K |
| 4 |
Osaic Holdings
Scottsdale,
Arizona
|
-$37.6K |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
1
DekaBank Deutsche Girozentrale
Frankfurt,
Germany
| $344K | – | – | – |
|
|
GCM
2
Greenland Capital Management
New York
| – | -$556K | -49,506 | Closed |
|
|
BIG
3
Brooklyn Investment Group
Brooklyn,
New York
| – | -$197K | -17,417 | Closed |
|
|
IA
4
IFP Advisors
Tampa,
Florida
| – | -$112K | -10,026 | Closed |
|
|
5
Osaic Holdings
Scottsdale,
Arizona
| – | -$37.6K | -3,344 | Closed |
|
VERV Hedge Fund Activity: Q4 2025 in Review
1 of the 8,223 institutional investors tracked by Wall St. Rank reported a position in Verve Therapeutics (VERV) for Q4 2025, worth a combined $344K — down 72% from $1.24M a quarter earlier.
Sellers outnumbered buyers: 5 funds closed out of VERV and 0 opened new positions — a net loss of 5 holders — while 0 trimmed existing stakes and 0 added.
The largest seller was Greenland Capital Management, exiting entirely with an estimated $556K sold.
- 1 institutional investor held Verve Therapeutics (VERV) as of Q4 2025, down from 6 in Q3 2025.
- Funds reported $344K of Verve Therapeutics stock for Q4 2025, down 72% quarter-over-quarter.
- 0 funds opened new Verve Therapeutics positions in Q4 2025 and 5 closed out, a net change of -5 holders.
- The largest Verve Therapeutics seller in Q4 2025 was Greenland Capital Management, an estimated $556K sold.
Based on aggregated 13F filings for Q4 2025.